Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer: a single-centre cohort study.
Jan M van ReesW HartmanJ J M E NuyttensE Oomen-de HoopJ L A van VugtJ RothbarthC VerhoefE van MeertenPublished in: BMC gastroenterology (2021)
Female patients and patients aged sixty-five or older had an increased risk of developing severe diarrhea during preoperative chemoradiation therapy with capecitabine. No relation was found between body composition and severe diarrhea.
Keyphrases
- body composition
- rectal cancer
- end stage renal disease
- locally advanced
- resistance training
- newly diagnosed
- ejection fraction
- bone mineral density
- chronic kidney disease
- peritoneal dialysis
- early onset
- patients undergoing
- prognostic factors
- clinical trial
- stem cells
- irritable bowel syndrome
- drug induced
- phase ii study
- middle aged
- metastatic breast cancer
- double blind
- patient reported